Live Breaking News & Updates on Taysha Gene Therapies Inc

Stay updated with breaking news from Taysha gene therapies inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Avoro Capital Advisors LLC Purchases 430,555 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA)

Avoro Capital Advisors LLC lifted its position in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) by 11.0% during the fourth quarter, Holdings Channel reports. The firm owned 4,355,555 shares of the company’s stock after acquiring an additional 430,555 shares during the period. Avoro Capital Advisors LLC’s holdings in Taysha Gene Therapies were […] ....

Piper Sandler , Canaccord Genuity Group , Taysha Gene Therapies Inc , Acuta Capital Partners , Avoro Capital Advisors , Vanguard Group Inc , Needham Company , Citigroup Inc , Jefferies Financial Group , Holdings Channel , Taysha Gene Therapies , Free Report , Capital Advisors , Capital Partners , Vanguard Group , Gene Therapies , Get Free Report , Financial Group , Visit Holdingschannel , Taysha Gene Therapies Daily ,

Is Taysha Gene Therapies, Inc. (NASDAQ:TSHA) the Best Gene Therapy Company?

We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Taysha Gene Therapies, Inc. ....

United States , Cathie Wood , Number Of Hedge Fund Holders , Gene Therapy Company , Taysha Gene Therapies Inc , Gene Therapy Stocks , Buy Now , Taysha Gene Therapies , North America , Best Gene Therapy , Insider Monkey , Gene Therapies , Hedge Fund Holders , Michael Burry Is Selling These Stocks , Jim Cramer , Recommending These ,

Cantor Fitzgerald Reaffirms "Overweight" Rating for Taysha Gene Therapies (NASDAQ:TSHA)

Cantor Fitzgerald restated their overweight rating on shares of Taysha Gene Therapies (NASDAQ:TSHA – Free Report) in a report issued on Tuesday morning, Benzinga reports. They currently have a $7.00 target price on the stock. A number of other equities research analysts have also recently issued reports on the stock. Piper Sandler began coverage on […] ....

Piper Sandler , China Universal Asset Management Co , Howard Capital Management Inc , Lee Financial Co , Canaccord Genuity Group , Victory Capital Management Inc , Dynamic Technology Lab Private Ltd , Taysha Gene Therapies Company Profile , Taysha Gene Therapies Inc , Cantor Fitzgerald , Needham Company , Taysha Gene Therapies , Free Report , Genuity Group , Gene Therapies Stock Down , Gene Therapies , Get Free Report , Capital Management , Technology Lab Private Ltd , Universal Asset Management , Taysha Gene Therapies Daily ,

Breaking Down Taysha Gene Therapies: 16 Analysts Share Their Views - Taysha Gene Therapies (NASDAQ:TSHA)

....

Taysha Gene Therapies Inc , Health Care , Taysha Gene Therapies , Analyst Ratings , Taysha Gene , Gene Therapies Inc , Revenue Trend , Examining Taysha Gene Therapies , What Are ,

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $7.00 Consensus Target Price from Analysts

Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) has been assigned a consensus rating of “Buy” from the nine ratings firms that are presently covering the firm, MarketBeat reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 1 year price objective among analysts that have covered the stock […] ....

Canaccord Genuity Group , Jefferies Financial Group , Taysha Gene Therapies Inc , Victory Capital Management Inc , Kovitz Investment Group Partners , China Universal Asset Management Co , Howard Capital Management Inc , Cantor Fitzgerald , Commonwealth Equity Services , Needham Company , Taysha Gene Therapies Company Profile , Taysha Gene Therapies , Get Free Report , Financial Group , Equity Services , Investment Group Partners , Capital Management , Universal Asset Management , Victory Capital Management , Gene Therapies , Get Free , Taysha Gene Therapies Daily ,